RBC Capital Downgrades Immunogen Inc. (IMGN) to Sector Perform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/16/2026

1. VRNS
2. CRWV
3. JBHT
4. TSLA
5. GPRK
6. SCHW
7. TRV
8. TFC
9. TECHM:IN
10. NVDA

Go back to RBC Capital Downgrades Immunogen Inc. (IMGN) to Sector Perform

ImmunoGen Reports Third Quarter Fiscal Year 2016 Financial Results and Provides Corporate Update

April 29, 2016 6:30 AM EDT

Conference call at 8:00 am ET today will include update on mirvetuximab soravtansine, the first folate receptor (FR)-targeting antibody-drug conjugate (ADC), including the design of the FORWARD I trial

WALTHAM, Mass.--(BUSINESS WIRE)-- ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company developing targeted cancer therapeutics using its proprietary ADC technology, today reported financial results for the three-month period ended March 31, 2016 the... More